We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKYH:NYSESky Harbour Group Corporation Analysis

Data as of 2026-09-09 - not real-time

$10.36

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sky Harbour Group Corporation is priced at $10.36 and its moving averages line up in bullish order, the shorter sitting above the longer. RSI sits at 46.3, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $10.01 and resistance around $11.70.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 56.2% above today's level. Revenue is growing at 49.6% on a 2.7% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 30.8%, a beta of 1.01 and a maximum drawdown of 21.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Sky Harbour Group SKYH delivered earnings and revenue surprises of +17.Sky Harbour Group Corp SKYH reports strong growth with new campus openings and pre-leasing success, despite slower...WEST HARRISON, N.Y., August 21, 2026--Sky Harbour Group Corporation NYSE: SKYH, SKYH WS "SHG" or the "Company" , an...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 9.67
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 9.67
  • Analyst targets imply +56.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +56.2% versus the current price
  • Negative return on equity of -6.8%
  • Revenue growth of +49.6%

Key Metrics & Analysis

Financial Health

Revenue Growth49.60%
Profit Margin2.73%
P/E Ratio-54.5
ROE-6.80%
ROA-2.46%
Debt/Equity370.79
P/B Ratio2.8
Op. Cash Flow$225.0K
Free Cash Flow$-242056880
Industry P/E31.3

Technical Analysis

TrendBullish
RSI46.3
Support$10.01
Resistance$11.70
MA 20$10.55
MA 50$10.43
MA 200$9.67
MACDBearish
VolumeDecreasing
Fear & Greed Index92.45

Valuation

Target Price$16.19
Upside/Downside56.25%
GradeFair
TypeGrowth

Risk Assessment

Beta1.01
Volatility30.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.